Golding A, Haque U, Giles J. Rheumatoid arthritis and reproduction. Rheum Dis Clin North Am. 2007;33:319–43.

PubMed  Google Scholar 

Smeele H, Dolhain R. Current perspectives on fertility, pregnancy and childbirth in patients with Rheumatoid Arthritis. Semin Arthritis Rheum. 2019;49:S32–5.

CAS  PubMed  Google Scholar 

de Jong P, Dolhain R. Fertility, Pregnancy, and Lactation in Rheumatoid Arthritis. Rheum Dis Clin North Am. 2017;43:227–37.

PubMed  Google Scholar 

Clowse M, Chakravarty E, Costenbader K, Chambers C, Michaud K. Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2012;64:668–74.

PubMed  Google Scholar 

Marcy D, Zell J, Demoruelle M. Rheumatoid Arthritis and Pregnancy: Managing Disease Activity and Fertility Concerns. Semin Reprod Med. 2024;42:169–77.

PubMed  Google Scholar 

De Cock D, Brants L, Soenen I, Pazmino S, Bertrand D, Stouten V, et al. A systematic review on the effect of DMARDs on fertility in rheumatoid arthritis. Semin Arthritis Rheum. 2020;50:873–8.

PubMed  Google Scholar 

Tański W, Dudek K, Tomasiewicz A, Świątoniowska-Lonc N. Sexual Dysfunction and Quality of Life in Patients with Rheumatoid Arthritis. Int J Environ Res Public Health. 2022;19:3088.

PubMed  PubMed Central  Google Scholar 

Pina Vegas L, Drouin J, Weill A, Dray-Spira R. Pregnancy outcomes in women with rheumatoid arthritis: an 11-year French nationwide study. RMD Open. 2024;10:e003762.

PubMed  PubMed Central  Google Scholar 

Nakai T, Fukui S, Ozawa H, Kitada A, Okada M, Kishimoto M. Management of pregnant with rheumatoid arthritis: preconception care, pregnancy and lactation strategies, and maternal-fetal outcomes. Best Pract Res Clin Rheumatol. 2025;39(1):102022. https://doi.org/10.1016/j.berh.2024.102022.

Kishore S, Mittal V, Majithia V. Obstetric outcomes in women with rheumatoid arthritis: Results from Nationwide Inpatient Sample Database 2003–2011. Semin Arthritis Rheum. 2019;49(2):236–40.

PubMed  Google Scholar 

Reed SD, Vollan TA, Svec MA. Pregnancy outcomes in women with rheumatoid arthritis in Washington State. Matern Child Health J. 2006;10:361–6.

PubMed  Google Scholar 

Hellgren K, Secher AE, Glintborg B, Rom AL, Gudbjornsson B, Michelsen B, et al. Pregnancy outcomes in relation to disease activity and anti-rheumatic treatment strategies in women with rheumatoid arthritis: a matched cohort study from Sweden and Denmark. Rheumatology (Oxford). 2022;61:3711–22.

CAS  PubMed  Google Scholar 

Secher AEP, Granath F, Glintborg B, Rom A, Hetland ML, Hellgren K. Risk of pre-eclampsia and impact of disease activity and antirheumatic treatment in women with rheumatoid arthritis, axial spondylarthritis and psoriatic arthritis: a collaborative matched cohort study from Sweden and Denmark. RMD Open. 2022;8:e002445.

PubMed  PubMed Central  Google Scholar 

Tsai YC, Chang HC, Chiou MJ, Luo SF, Kuo CF. Fetal-neonatal and maternal pregnancy outcomes in women with rheumatoid arthritis: a population-based cohort study. BMJ Open. 2022;12:e059203.

PubMed  PubMed Central  Google Scholar 

Zahid S, Mohamed MS, Rajendran A, Minhas AS, Khan MZ, Nazir NT, et al. Rheumatoid arthritis and cardiovascular complications during delivery: a United States inpatient analysis. Eur Heart J. 2024;45:1524–36.

PubMed  PubMed Central  Google Scholar 

Förger F, Villiger PM. Immunological adaptations in pregnancy that modulate rheumatoid arthritis disease activity. Nat Rev Rheumatol. 2020;16:113–22.

PubMed  Google Scholar 

Jethwa H, Lam S, Smith C, Giles I. Does Rheumatoid Arthritis Really Improve During Pregnancy? A Systematic Review and Metaanalysis. J Rheumatol. 2019;46:245–50.

PubMed  Google Scholar 

Nakamura E, Kotani T, Hiramatsu Y, Hata K, Yoshikawa A, Matsumura Y, et al. Simplified disease activity index and clinical disease activity index before and during pregnancy correlate with those at postpartum in patients with rheumatoid arthritis. Mod Rheumatol. 2021;31:809–16.

CAS  PubMed  Google Scholar 

Smeele HT, Röder E, Wintjes HM, Kranenburg-van Koppen LJ, Hazes JM, Dolhain RJ. Modern treatment approach results in low disease activity in 90% of pregnant rheumatoid arthritis patients: the PreCARA study. Ann Rheum Dis. 2021;80:859–64.

CAS  PubMed  Google Scholar 

Gerardi MC, Crisafulli F, García-Fernandez A, Lini D, Bazzani C, Cavazzana I, et al. Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis. Front Pharmacol. 2022;13:887462.

CAS  PubMed  PubMed Central  Google Scholar 

Hughes GC. Progesterone and autoimmune disease. Autoimmun Rev. 2012;11:A502–14.

CAS  PubMed  Google Scholar 

Pathi A, Wright M, Smed MK, Nelson JL, Olsen J, Hetland ML, et al. The Rheumatoid Arthritis Gene Expression Signature Among Women Who Improve or Worsen During Pregnancy: A Pilot Study. J Rheumatol. 2021;48:985–91.

CAS  PubMed  Google Scholar 

Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, et al. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol. 2020;72:529–56.

PubMed  Google Scholar 

Birru Talabi M, Eudy AM, Jayasundara M, Haroun T, Nowell WB, Curtis JR, et al. Pregnancy, Periods, and “The Pill”: Exploring the Reproductive Experiences of Women with Inflammatory Arthritis. ACR Open Rheumatol. 2019;1:125–32.

PubMed  PubMed Central  Google Scholar 

Wolgemuth T, Stransky OM, Chodoff A, Kazmerski TM, Clowse MEB, Birru TM. Exploring the Preferences of Women Regarding Sexual and Reproductive Health Care in the Context of Rheumatology: A Qualitative Study. Arthritis Care Res (Hoboken). 2021;73:1194–200.

PubMed  Google Scholar 

Castro-Gutierrez A, Young K, Bermas BL. Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome. Rheum Dis Clin North Am. 2022;48:523–35.

PubMed  Google Scholar 

Rüegg L, Pluma A, Hamroun S, Cecchi I, Perez-Garcia LF, Anderson PO, et al. EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update. Ann Rheum Dis. 2025;S0003–4967(25):00818.

Google Scholar 

Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A, et al. British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford). 2023;62:e48–88.

PubMed  Google Scholar 

Mother to Baby. https://mothertobaby.org. Accessed 13 Apr 2025

American College of Rheumatology. Reproductive Health Initiative. https://rheumatology.org/reproductive-health-initiative. Accessed 30 Jan 2025

U.S. Food and Drug Administration. Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Drug Safety Communication, Avoid Use of NSAIDs in Pregnancy at 20 Weeks or Later. October 2020. https://www.fda.gov/safety/medical-product-safety-information/nonsteroidal-anti-inflammatory-drugs-nsaids-drug-safety-communication-avoid-use-nsaids-pregnancy-20#:~:text=FDA%20recommends%20that%20health%20care,dose%20and%20shortest%20duration%20possible. Accessed 19 Feb 2025

Castro CT, Gama RS, Pereira M, Oliveira MG, Dal-Pizzol TS, Barreto ML, et al. Effect of Acetaminophen use during pregnancy on adverse pregnancy outcomes: a systematic review and meta-analysis. Expert Opin Drug Saf. 2022;21:241–51.

CAS  PubMed  Google Scholar 

Bandoli G, Palmsten K, Forbess Smith CJ, Chambers CD. A Review of Systemic Corticosteroid Use in Pregnancy and the Risk of Select Pregnancy and Birth Outcomes. Rheum Dis Clin North Am. 2017;43:489–502.

PubMed  PubMed Central  Google Scholar 

Palmsten K, Bandoli G, Vazquez-Benitez G, Xi M, Johnson DL, Xu R, Chambers CD. Oral corticosteroid use during pregnancy and risk of preterm birth. Rheumatology (Oxford). 2020;59:1262–71.

CAS  PubMed  Google Scholar 

Luo L, Li X, Yan R, Zhang H, Li C. Risk factors for adverse pregnancy outcomes in women with rheumatoid arthritis and follow-up of their offspring. Clin Rheumatol. 2022;41:3135–41.

PubMed  Google Scholar 

Balevic S, Sims CA, Eudy A, Smith V, Clowse M. Azathioprine metabolite levels and outcomes during pregnancies with rheumatic disease. Lupus Sci Med. 2024;11:e001036.

PubMed  PubMed Central  Google Scholar 

Siegel CH, Sammaritano LR. Safety of Medications Used to Treat Autoimmune Rheumatic Diseases During Pregnancy and Lactation. J Clin Rheumatol. 2024;30(7S Suppl 1):S25–33.

PubMed  Google Scholar 

Grindulis KA, McConkey B. Does sulphasalazine cause folate deficiency in rheumatoid arthritis? Scand J Rheumatol. 1985;14:265–70.

CAS  PubMed  Google Scholar 

U.S. Food and Drug Administration. FDA Alerts Health Care Professionals of Pregnancy Problems Associated with Thiopurines. April 2024. https://www.fda.gov/drugs/drug-safety-and-availability/fda-alerts-health-care-professionals-pregnancy-problems-associated-thiopurines. Accessed 28 Feb 2025

Wang H, Hu Y, Chen F, Shen M. Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis. BMC Pregnancy Childbirth. 2022;22:854.

PubMed  PubMed Central  Google Scholar 

Ghalandari N, Kemper E, Crijns IH, Wolbink G, Rispens T, Smeele HT, et al. Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy. Ann Rheum Dis. 2022;81:402–5.

CAS  PubMed  Google Scholar 

Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood. 2011;117:1499–506.

CAS  PubMed  Google Scholar 

Drugs and Lactation Database (LactMed). National Center for Biotechnology Information.